McKesson Corporation $MCK Stock Bought by International Assets Investment Management LLC

International Assets Investment Management LLC increased its stake in shares of McKesson Corporation (NYSE:MCK) by 9,208.5% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 70,000 shares of the company’s stock after buying an additional 69,248 shares during the quarter. International Assets Investment Management LLC owned 0.06% of McKesson worth $59,767,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also bought and sold shares of MCK. Rosenberg Matthew Hamilton grew its stake in shares of McKesson by 2.8% in the 3rd quarter. Rosenberg Matthew Hamilton now owns 406 shares of the company’s stock worth $347,000 after acquiring an additional 11 shares in the last quarter. Avail Investment Partners LLC lifted its position in shares of McKesson by 1.7% during the third quarter. Avail Investment Partners LLC now owns 662 shares of the company’s stock valued at $566,000 after purchasing an additional 11 shares in the last quarter. Commonwealth Financial Services LLC boosted its position in McKesson by 3.8% in the third quarter. Commonwealth Financial Services LLC now owns 304 shares of the company’s stock worth $260,000 after purchasing an additional 11 shares during the last quarter. Stephens Inc. AR grew its stake in McKesson by 0.8% in the 1st quarter. Stephens Inc. AR now owns 1,581 shares of the company’s stock valued at $1,368,000 after purchasing an additional 12 shares during the period. Finally, WealthPLAN Partners LLC grew its stake in McKesson by 0.4% in the 3rd quarter. WealthPLAN Partners LLC now owns 3,190 shares of the company’s stock valued at $2,724,000 after purchasing an additional 12 shares during the period. 85.07% of the stock is owned by hedge funds and other institutional investors.

McKesson Trading Up 1.4%

Shares of NYSE MCK opened at $994.77 on Friday. The stock has a fifty day simple moving average of $922.54 and a two-hundred day simple moving average of $862.89. McKesson Corporation has a 1-year low of $723.68 and a 1-year high of $1,030.27. The firm has a market cap of $115.98 billion, a price-to-earnings ratio of 26.62, a price-to-earnings-growth ratio of 1.95 and a beta of 0.30.

McKesson (NYSE:MCK) last issued its earnings results on Wednesday, August 5th. The company reported $9.93 earnings per share (EPS) for the quarter, beating the consensus estimate of $9.56 by $0.37. The firm had revenue of $105.38 billion for the quarter, compared to analyst estimates of $103.88 billion. McKesson had a negative return on equity of 253.21% and a net margin of 1.12%. The business’s revenue was up 7.7% on a year-over-year basis. During the same period in the previous year, the company posted $8.26 earnings per share. McKesson has set its FY 2027 guidance at 44.200-45.000 EPS. Analysts forecast that McKesson Corporation will post 44.71 EPS for the current year.

McKesson Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, January 4th. Investors of record on Tuesday, December 1st will be paid a $0.94 dividend. This represents a $3.76 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date is Tuesday, December 1st. McKesson’s payout ratio is currently 10.06%.

Insider Activity at McKesson

In other McKesson news, EVP Francisco Fraga sold 800 shares of the company’s stock in a transaction dated Thursday, October 15th. The shares were sold at an average price of $995.80, for a total transaction of $796,640.00. Following the sale, the executive vice president directly owned 5,423 shares of the company’s stock, valued at $5,400,223.40. This represents a 12.86% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Bradley Lerman sold 301 shares of the stock in a transaction dated Monday, August 10th. The stock was sold at an average price of $892.33, for a total transaction of $268,591.33. The disclosure for this sale is available in the SEC filing. In the last three months, insiders have sold 1,212 shares of company stock worth $1,164,182. Company insiders own 0.06% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on MCK. Evercore reiterated an “outperform” rating and set a $950.00 target price (down from $1,000.00) on shares of McKesson in a research note on Thursday, August 6th. Robert W. Baird set a $1,015.00 price target on shares of McKesson in a report on Thursday, August 6th. Mizuho increased their price target on shares of McKesson from $905.00 to $1,020.00 and gave the company a “neutral” rating in a research report on Tuesday, October 20th. Royal Bank Of Canada restated a “sector perform” rating and set a $845.00 price objective on shares of McKesson in a report on Monday, September 14th. Finally, Wall Street Zen raised shares of McKesson from a “hold” rating to a “buy” rating in a research report on Saturday, October 17th. Fifteen research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $997.12.

McKesson Company Profile

McKesson Corporation is a healthcare services and information technology company that distributes pharmaceuticals and medical products to pharmacies, hospitals, health systems, physicians and other healthcare providers. The company also provides technology, data and business solutions designed to support prescription management, pharmacy operations and patient care.

McKesson’s principal activities include pharmaceutical distribution, medical-surgical supply distribution, specialty pharmaceutical services and oncology care support.